Provides a preview of the volume of its patient visit and interactions in Q4-2022. The Company expects to announce another record performance for total omni-channel patient visits in Q4-2022 reflecting approximately a YoY increase of 42% and a QoQ growth of 11%. WELL's growth was primarily driven by organic growth. The Company also achieved ~4.9 million patient interactions for the full year 2022, an increase of 86% as compared to 2021. WELL Health Technologies Corp. shares T.WELL are trading up $0.12 at $4.32.
Stocks in play: WELL Health Technologies Corp.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)
